Most diseases are still poorly understood at a biological level. Despite decades of research, the causal mechanisms driving many conditions remain unclear, limiting our ability to identify the right targets, design the right interventions and bring the right medicines to patients.
The AI Accelerator exists to change that. Based in London and sitting within Computational Innovation (@computationalinnovation), a global organisation spanning computational biology, human genetics, data excellence and AI, the Accelerator’s mission is to build production-quality AI capabilities that deepen our understanding of disease biology and increase probability of success.
We do this by applying neural-based methods across the biomedical data landscape to integrate heterogeneous, multimodal data sources, infer biological relationships and embed causal thinking into what we build. The goal is not just to predict but to explain and understand why disease occurs.
It could be electronic health records and medical imaging to support patient segmentation. It could be ‘omics data to identify novel therapeutic targets. It could be predicting transcriptional change for a given disease-causing variant. It could be simulating the effect of modulating a target of interest.
A core component of the AI Accelerator is AI Systems, a team focused on designing, building and deploying multimodal foundation models across the vast biomedical data landscape that will be used within Computational Innovation to enhance and accelerate portfolio decision-making.
We are seeking a senior leader of AI Systems to join Computational Innovation’s AI Accelerator (@computationalinnovation). In this role you will build and lead a team of world-class AI scientists and ML engineers who can design novel architectures that can train and infer at scale while respecting the complexity and structure of biomedical data, engineer the most promising models and model components and deliver production-quality models and model artefacts for deployment to computational biologists and human geneticists for portfolio impact.
The successful candidate will be part of the AI Accelerator Leadership Team and play a key role in shaping the AI strategy and delivering on the mission. This is a unique opportunity to be part of a critical strategic initiative for a pharmaceutical company that invests heavily in research and development to discover and develop innovative therapies that can improve and extend lives in areas of high unmet medical need.
This is a hybrid role with approximately 4 days a week in the office.
Boehringer Ingelheim has been recognised as a Top Employer in the UK, demonstrating our commitment to building an exceptional workplace through strong people practices and supportive HR policies.
To learn more about why BI is a great place to work, visit:
https://www.boehringer-ingelheim.co.uk/careers/uk-careers/why-great-place-work

Our people are our strength. And together with over 54,000 colleagues, we're creating the next breakthrough in the world of healthcare and innovation for both humans and animals. Are you ready to join us? #LifeForward
Privacy Notice: https://www.boehringer-ingelheim.com/privacy-notice
Imprint: https://www.boehringer-ingelheim.com/imprint